Profound Mishandling of Protein Glycation Degradation Products in Uremia and Dialysis
- 1 May 2005
- journal article
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 16 (5) , 1471-1485
- https://doi.org/10.1681/asn.2004080635
Abstract
The aim of this study was to define the severe deficits of protein glycation adduct clearance in chronic renal failure and elimination in peritoneal dialysis (PD) and hemodialysis (HD) therapy using a liquid chromatography-triple quadrupole mass spectrometric detection method. Physiologic proteolysis of proteins damaged by glycation, oxidation, and nitration forms protein glycation, oxidation, and nitration free adducts that are released into plasma for urinary excretion. Inefficient elimination of these free adducts in uremia may lead to their accumulation. Patients with mild uremic chronic renal failure had plasma glycation free adduct concentrations increased up to five-fold associated with a decline in renal clearance. In patients with ESRD, plasma glycation free adducts were increased up to 18-fold on PD and up to 40-fold on HD. Glycation free adduct concentrations in peritoneal dialysate increased over 2- to 12-h dwell time, exceeding the plasma levels markedly. Plasma glycation free adducts equilibrated rapidly with dialysate of HD patients, with both plasma and dialysate concentrations decreasing during a 4-h dialysis session. It is concluded that there are severe deficits of protein glycation free adduct clearance in chronic renal failure and in ESRD on PD and HD therapy.Keywords
This publication has 32 references indexed in Scilit:
- Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membraneKidney International, 2004
- AGEs in foods: Do they play a role in uremia?Kidney International, 2003
- Review on uremic toxins: Classification, concentration, and interindividual variabilityKidney International, 2003
- 8-Iso-Prostaglandin F2α as a Useful Clinical Biomarker of Oxidative Stress in ESRD PatientsBlood Purification, 2002
- Monocyte-Related Determinants of Inflammation in Patients on Peritoneal DialysisAmerican Journal of Nephrology, 2001
- Atherosclerotic cardiovascular disease risks in chronic hemodialysis patientsKidney International, 2000
- Increase in Three α,β-Dicarbonyl Compound Levels in Human Uremic Plasma: Specificin VivoDetermination of Intermediates in Advanced Maillard ReactionBiochemical and Biophysical Research Communications, 1999
- The peritoneal dialysis systemNephrology Dialysis Transplantation, 1998
- Age-dependent increase in ortho-tyrosine and methionine sulfoxide in human skin collagen is not accelerated in diabetes. Evidence against a generalized increase in oxidative stress in diabetes.Journal of Clinical Investigation, 1997
- Identification of N.epsilon.-carboxymethyllysine: a new Maillard reaction product in rat urineJournal of Agricultural and Food Chemistry, 1987